Scan This Qr Code to View the Impressive Bibiography of Coms

INTRODUCTION The Collaborative Ocular Melanoma Study (COMS) was the largest study ever to be funded and performed in ocular oncology. With 43 participating centers and hundreds of investigators, more than 2000 patients enrolled, 28 numbered studies published over a period of 16 years and almost innumerable editorials, letters, comments, and review articles generated by its findings, the breadth and depth of the knowledge produced by the COMS is unparalleled in ophthalmic oncology. To develop a sense of the legacy of the COMS and its effect on clinical practice in ocular oncology, Retina Today interviewed Timothy G. Murray, MD, MBA, FACS, who was the Principal Investigator for the COMS at Bascom Palmer Eye Institute at the Miller School of Medicine of the University of Miami.